Edition:
United States

Biocartis Group NV (BCART.BR)

BCART.BR on Brussels Stock Exchange

12.40EUR
9:34am EDT
Change (% chg)

€0.18 (+1.47%)
Prev Close
€12.22
Open
€12.40
Day's High
€12.50
Day's Low
€12.26
Volume
48,321
Avg. Vol
95,430
52-wk High
€15.00
52-wk Low
€9.51

Chart for

About

Biocartis Group NV is a Belgium-based company, which specializes in the development of molecular diagnostic systems, especially for the treatment of cancers and infectious diseases, the products ensure the analysis of biomolecules associated with risk factors, early detection, treatment selection and monitoring of disease. The... (more)

Overall

Beta: --
Market Cap(Mil.): €626.17
Shares Outstanding(Mil.): 51.33
Dividend: --
Yield (%): --

Financials

  BCART.BR Industry Sector
P/E (TTM): -- 39.42 32.59
EPS (TTM): -0.93 -- --
ROI: -28.76 14.34 12.60
ROE: -36.63 17.22 14.49

BRIEF-Biocartis FY Total Operating Income Up At 23.1 Million Euros

* FY TOTAL OPERATING INCOME: EQUALED EUR 23.1M IN 2017 COMPARED TO EUR 13.8M IN 2016,

Mar 01 2018

BRIEF-The EU Provides Biocartis With Up To 24 Million Euros Debt For Infectious Disease Projects

* REG-BIOCARTIS GROUP NV: EUROPEAN UNION PROVIDES BIOCARTIS WITH UP TO EUR 24M DEBT FINANCING FACILITY FOR INFECTIOUS DISEASE PROJECTS

Mar 01 2018

BRIEF-Biocartis And Amgen Sign New Agreement

* REG-BIOCARTIS GROUP NV: BIOCARTIS AND AMGEN SIGN NEW COMPANION DIAGNOSTIC AGREEMENT FOR NOVEL ONCOLOGY COMPOUND

Jan 09 2018

BRIEF-Biocartis And Amgen Sign Companion Diagnostic Agreement For Idylla(Tm) RAS Biomarker Tests

* BIOCARTIS AND AMGEN SIGN COMPANION DIAGNOSTIC AGREEMENT FOR IDYLLA(TM) RAS BIOMARKER TESTS

Dec 04 2017

BRIEF-Biocartis Raises 80 Million Dollars

* ANNOUNCED ON TUESDAY THAT IT RAISED EUR 80 MILLION IN GROSS PROCEEDS

Nov 29 2017

BRIEF-Bookrunner says Biocartis Group deal upsized to 80 mln euros From 60 mln euros base deal size‍​

* BLOCK TRADE- BIOCARTIS GROUP NV: BOOKRUNNER SAYS DEAL UPSIZED TO 80 MILLION EUROS FROM 60 MILLION EUROS BASE DEAL SIZE‍​

Nov 28 2017

BRIEF-Biocartis Share Offering Of Up To About 8.9 mln Shares ‍​- bookrunner

* SAYS OFFERING DEAL SIZE ABOUT 60 MILLION EUROS‍​ Further company coverage:

Nov 28 2017

BRIEF-Biocartis Launches Equity Placement

* REG-BIOCARTIS GROUP NV: BIOCARTIS LAUNCHES EQUITY PLACEMENT

Nov 28 2017

BRIEF-Biocartis Group Launches Liquid Biopsy Tests with Merck

* ‍TESTS DEVELOPED UNDER PARTNERSHIP WITH MERCK KGAA, DARMSTADT, GERMANY​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Nov 27 2017

Earnings vs. Estimates